Trastuzumab decreases the incidence of clinical relapses in patients with early breast cancer presenting chemotherapy-resistant CK-19mRNA-positive circulating tumor cells: results of a randomized phase II study
Georgoulias, V., Bozionelou, V., Agelaki, S., Perraki, M., Apostolaki, S., Kallergi, G., Kalbakis, K., Xyrafas, A., Mavroudis, D.Volume:
23
Language:
english
Journal:
Annals of Oncology
DOI:
10.1093/annonc/mds020
Date:
July, 2012
File:
PDF, 195 KB
english, 2012